MYFED Drug Patent Profile
✉ Email this page to a colleague
When do Myfed patents expire, and when can generic versions of Myfed launch?
Myfed is a drug marketed by Usl Pharma and is included in one NDA.
The generic ingredient in MYFED is pseudoephedrine hydrochloride; triprolidine hydrochloride. There are forty-nine drug master file entries for this compound. Additional details are available on the pseudoephedrine hydrochloride; triprolidine hydrochloride profile page.
Summary for MYFED
US Patents: | 0 |
Applicants: | 1 |
NDAs: | 1 |
Raw Ingredient (Bulk) Api Vendors: | 33 |
Patent Applications: | 5,675 |
Formulation / Manufacturing: | see details |
DailyMed Link: | MYFED at DailyMed |
Anatomical Therapeutic Chemical (ATC) Classes for MYFED
US Patents and Regulatory Information for MYFED
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Usl Pharma | MYFED | pseudoephedrine hydrochloride; triprolidine hydrochloride | SYRUP;ORAL | 088116-001 | Mar 4, 1983 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |